{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,7]],"date-time":"2026-11-07T02:53:42Z","timestamp":1794020022810,"version":"4.8.0"},"reference-count":18,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"33","license":[{"start":{"date-parts":[[2025,8,15]],"date-time":"2025-08-15T00:00:00Z","timestamp":1755216000000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2025,8,15]]},"abstract":"<jats:sec>\n                    <jats:title>Rationale:<\/jats:title>\n                    <jats:p>Familial hypomagnesemia with hypercalciuria and nephrocalcinosis (FHHNC) is a rare autosomal recessive renal tubular disorder caused by mutations in the CLDN16 or CLDN19 genes. This case demonstrates the critical role of whole-exome sequencing (WES) in diagnosing FHHNC, particularly when novel mutations, such as the homozygous CLDN16 variant (c.351G\u2005&gt;\u2005T, p.W117C) found in this patient, are identified, which expands the genetic understanding of this condition.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Patient concerns:<\/jats:title>\n                    <jats:p>A 17-year-old female presented with an 8-month history of persistent neck, shoulder, and upper limb pain that had worsened over the past month. Despite initial treatment for cervical degenerative disease at local hospitals, her symptoms showed minimal improvement. She also exhibited growth retardation, with a height of 145\u2009cm (\u22122 SD), and experienced recurrent urinary tract infections, although she reported no visual disturbances or neurological symptoms.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Diagnoses:<\/jats:title>\n                    <jats:p>Laboratory tests revealed hypomagnesemia and elevated parathyroid hormone levels. Imaging studies confirmed bilateral nephrocalcinosis and a medullary sponge kidney. Genetic testing using WES identified a homozygous pathogenic mutation in CLDN16 (c.351G\u2005&gt;\u2005T), which was further validated by Sanger sequencing in the patient and her heterozygous parents.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Interventions:<\/jats:title>\n                    <jats:p>During hospitalization, the patient received intravenous magnesium sulfate (2.5\u2009g\/day), oral calcium carbonate with vitamin D3 supplementation, and levofloxacin for urinary tract infection management. Upon discharge, she was maintained on oral magnesium oxide (500\u2009mg twice daily) with regular monitoring of electrolyte levels and renal function.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Outcomes:<\/jats:title>\n                    <jats:p>At the 2-year follow-up, the patient\u2019s serum magnesium levels improved but remained below the normal range. Hypercalciuria persisted, although her renal function was stable. Notably, there was no progression to end-stage renal disease, and her symptoms were better managed with ongoing treatment.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Lessons:<\/jats:title>\n                    <jats:p>This case underscores the importance of WES in the diagnosis of rare tubular disorders, especially when the clinical presentations are nonspecific. This finding highlights that CLDN16-related FHHNC can occur without ocular involvement, and this information may aid in differential diagnosis. Early and consistent magnesium supplementation appears to mitigate renal deterioration, emphasizing the need for prompt intervention. Additionally, this case reinforces the value of genetic counseling for families affected by autosomal recessive conditions.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1097\/md.0000000000043839","type":"journal-article","created":{"date-parts":[[2025,8,18]],"date-time":"2025-08-18T19:01:46Z","timestamp":1755543706000},"page":"e43839","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":2,"title":["Whole exome sequencing reveals a pathogenic homozygous CLDN16 mutation in a 17-year-old patient with familial hypomagnesemia with hypercalciuria and nephrocalcinosis: A case report"],"prefix":"10.1097","volume":"104","author":[{"given":"Fei","family":"Wang","sequence":"first","affiliation":[{"name":"Department of Endocrinology, The First Affiliated Hospital of Xinjiang Medical University, Urumqi, China"},{"name":"State Key Laboratory of Pathogenesis, Prevention and Treatment of High Incidence Diseases in Central Asia, Urumqi, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0003-9402-8601","authenticated-orcid":false,"given":"Yilinuer","family":"Adeerjiang","sequence":"additional","affiliation":[{"name":"Department of Endocrinology, The First Affiliated Hospital of Xinjiang Medical University, Urumqi, China"},{"name":"State Key Laboratory of Pathogenesis, Prevention and Treatment of High Incidence Diseases in Central Asia, Urumqi, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hai-Qing","family":"Xing","sequence":"additional","affiliation":[{"name":"College of Pharmacy, Macau University of Science and Technology, Macau Special Administrative Region, China."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7932-235X","authenticated-orcid":false,"given":"Sheng","family":"Jiang","sequence":"additional","affiliation":[{"name":"Department of Endocrinology, The First Affiliated Hospital of Xinjiang Medical University, Urumqi, China"},{"name":"State Key Laboratory of Pathogenesis, Prevention and Treatment of High Incidence Diseases in Central Asia, Urumqi, China"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-20260911","doi-asserted-by":"crossref","first-page":"3045","DOI":"10.1007\/s00467-021-04968-2","article-title":"Familial hypomagnesemia with hypercalciuria and nephrocalcinosis.","volume":"36","author":"Vall-Palomar","year":"2021","journal-title":"Pediatr Nephrol"},{"key":"R2-20260911","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1055\/s-0041-1733852","article-title":"Familial hypomagnesemia with hypercalciuria, nephrocalcinosis, and bilateral chorioretinal atrophy in a patient with homozygous p.G75S variant in CLDN19.","volume":"10","author":"Rahmani","year":"2021","journal-title":"J Pediatr Genet"},{"key":"R3-20260911","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1126\/science.285.5424.103","article-title":"Paracellin-1, a renal tight junction protein required for paracellular Mg2+ resorption.","volume":"285","author":"Simon","year":"1999","journal-title":"Science"},{"key":"R4-20260911","doi-asserted-by":"crossref","first-page":"949","DOI":"10.1086\/508617","article-title":"Mutations in the tight-junction gene claudin 19 (CLDN19) are associated with renal magnesium wasting, renal failure, and severe ocular involvement.","volume":"79","author":"Konrad","year":"2006","journal-title":"Am J Hum Genet"},{"key":"R5-20260911","doi-asserted-by":"crossref","first-page":"F1337","DOI":"10.1152\/ajprenal.00273.2015","article-title":"Ways of calcium reabsorption in the kidney.","volume":"310","author":"Moor","year":"2016","journal-title":"Am J Physiol Renal Physiol"},{"key":"R6-20260911","doi-asserted-by":"crossref","first-page":"1257","DOI":"10.2215\/CJN.09750913","article-title":"Correction. Renal control of calcium, phosphate, and magnesium homeostasis.","volume":"10","author":"Blaine","year":"2015","journal-title":"Clin J Am Soc Nephrol"},{"key":"R7-20260911","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1007\/BF00849255","article-title":"Hypomagnesaemia of hereditary renal origin.","volume":"1","author":"Rodriguez-Soriano","year":"1987","journal-title":"Pediatr Nephrol"},{"key":"R8-20260911","doi-asserted-by":"crossref","first-page":"889","DOI":"10.1038\/ejhg.2014.176","article-title":"Clinical utility gene card for: familial hypomagnesemia with hypercalciuria and nephrocalcinosis with\/without severe ocular involvement.","volume":"23","author":"Claverie-Martin","year":"2015","journal-title":"Eur J Hum Genet"},{"key":"R9-20260911","doi-asserted-by":"crossref","first-page":"355","DOI":"10.2215\/CJN.02870310","article-title":"Renal, ocular, and neuromuscular involvements in patients with CLDN19 mutations.","volume":"6","author":"Faguer","year":"2011","journal-title":"Clin J Am Soc Nephrol"},{"key":"R10-20260911","doi-asserted-by":"crossref","first-page":"288","DOI":"10.1007\/s10157-008-0126-6","article-title":"Familial hypomagnesemia with hypercalciuria and nephrocalcinosis: unusual clinical associations and novel claudin16 mutation in an Egyptian family.","volume":"13","author":"Al-Haggar","year":"2009","journal-title":"Clin Exp Nephrol"},{"key":"R11-20260911","doi-asserted-by":"crossref","first-page":"636","DOI":"10.1093\/ndt\/gfu374","article-title":"Retrospective cohort study of familial hypomagnesaemia with hypercalciuria and nephrocalcinosis due to CLDN16 mutations.","volume":"30","author":"Sikora","year":"2015","journal-title":"Nephrol Dial Transplant"},{"key":"R12-20260911","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1007\/BF00856522","article-title":"Pathophysiology of the renal acidification defect present in the syndrome of familial hypomagnesaemia-hypercalciuria.","volume":"8","author":"Rodriguez-Soriano","year":"1994","journal-title":"Pediatr Nephrol"},{"key":"R13-20260911","doi-asserted-by":"crossref","first-page":"656","DOI":"10.1093\/ckj\/sfv081","article-title":"Familial hypomagnesaemia with hypercalciuria and nephrocalcinosis: clinical and molecular characteristics.","volume":"8","author":"Claverie-Martin","year":"2015","journal-title":"Clin Kidney J"},{"key":"R14-20260911","doi-asserted-by":"crossref","first-page":"208","DOI":"10.4103\/0974-7796.134261","article-title":"Effects of hydrochlorothiazide on kidney stone therapy with extracorporeal shock wave lithotripsy.","volume":"6","author":"Tehranchi","year":"2014","journal-title":"Urol Ann"},{"key":"R15-20260911","doi-asserted-by":"crossref","first-page":"825","DOI":"10.7326\/0003-4819-158-11-201306040-00007","article-title":"Evaluation and management of chronic kidney disease: synopsis of the kidney disease: improving global outcomes 2012 clinical practice guideline.","volume":"158","author":"Stevens","year":"2013","journal-title":"Ann Intern Med"},{"key":"R16-20260911","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1681\/ASN.2014090947","article-title":"Normal 25-hydroxyvitamin D levels are associated with less proteinuria and attenuate renal failure progression in children with CKD.","volume":"27","author":"Shroff","year":"2016","journal-title":"J Am Soc Nephrol"},{"key":"R17-20260911","doi-asserted-by":"crossref","first-page":"801","DOI":"10.2215\/CJN.12841211","article-title":"Familial hypomagnesemia with hypercalciuria and nephrocalcinosis: phenotype-genotype correlation and outcome in 32 patients with CLDN16 or CLDN19 mutations.","volume":"7","author":"Godron","year":"2012","journal-title":"Clin J Am Soc Nephrol"},{"key":"R18-20260911","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1016\/j.cca.2016.04.004","article-title":"A novel mutation in CLDN16 results in rare familial hypomagnesaemia with hypercalciuria and nephrocalcinosis in a Chinese family.","volume":"457","author":"Lv","year":"2016","journal-title":"Clin Chim Acta"}],"container-title":["Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/10.1097\/MD.0000000000043839","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,11]],"date-time":"2026-09-11T19:02:17Z","timestamp":1789153337000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/10.1097\/MD.0000000000043839"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,8,15]]},"references-count":18,"journal-issue":{"issue":"33","published-print":{"date-parts":[[2025]]}},"URL":"https:\/\/doi.org\/10.1097\/md.0000000000043839","relation":{},"ISSN":["1536-5964","0025-7974"],"issn-type":[{"value":"1536-5964","type":"electronic"},{"value":"0025-7974","type":"print"}],"subject":[],"published":{"date-parts":[[2025,8,15]]},"assertion":[{"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2025-07-17","name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}}]}}